LAVA THERAPEUTICS NV's ticker is LVTX and the CUSIP is N51517105. A total of 19 filers reported holding LAVA THERAPEUTICS NV in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $30,000 | – | 2,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Novo Holdings A/S | 3,327,312 | $19,698,000 | 1.02% |
| Redmile Group, LLC | 2,816,196 | $16,672,000 | 0.29% |
| Nicholas Investment Partners, LP | 528,953 | $3,131,000 | 0.23% |
| DAFNA Capital Management LLC | 139,332 | $825,000 | 0.22% |
| SPHERA FUNDS MANAGEMENT LTD. | 215,359 | $1,275,000 | 0.11% |
| Nantahala Capital Management | 369,290 | $2,186,000 | 0.07% |
| Alpha Wave Global, LP | 140,229 | $830,000 | 0.06% |
| Artal Group S.A. | 200,000 | $1,184,000 | 0.03% |
| AXA S.A. | 229,121 | $1,356,000 | 0.00% |
| Point72 Asset Management, L.P. | 123,911 | $734,000 | 0.00% |